Intensified Antiplatelet Treatment Reduces Major Cardiac Events in Patients with Clopidogrel Low Response: A Meta-analysis of Randomized Controlled Trials

Intensified Antiplatelet Treatment Reduces Major Cardiac Events in Patients with Clopidogrel Low Response: A Meta-analysis of Randomized Controlled Trials

Background: Clopidogrel low response (CLR) is an independent risk factor of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI), and intensified antiplatelet treatments (IAT) guided by platelet function assays might overcome laboratory CLR. However, whether IAT improves...

Full description

Bibliographic Details
Main Authors: Lei Xu, Xiao-Wei Hu, Shu-Hua Zhang, Ji-Min Li, Hui Zhu, Ke Xu, Jun Chen, Chun-Jian Li
Format: Article
Language:English
Published: Wolters Kluwer 2016-01-01
Series:Chinese Medical Journal
Subjects:
Coronary Artery Disease; Individualized Medicine; Platelet Aggregation Inhibitor; Platelet Function Test
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=8;spage=984;epage=991;aulast=Xu

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=8;spage=984;epage=991;aulast=Xu

Similar Items